Sb202474. We previously determined that the inactive analog of sb 202190, sb202474 (calbiochem) had no effects on pathway activation or astrocyte morphology. * please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Dmso, the diluent/vehicle control for all drugs used in this study, was also. A negative control for map kinase inhibition studies.
View Interactive Charts Of Activity Data Across Species.
The arrowheads indicate mk2 splice variants.
Sb 202474, Which Has No Ability To Inhibit P38 Mapk Activity And Is Widely Used As A Negative Control Compound In P38 Mapk Studies, Also Suppressed Melanin Synthesis Induction.
Sb 202474, a negative analog of sb203580.
* Please Kindly Note That Our Products Are Not To Be Used For Therapeutic Purposes And Cannot Be Sold To Patients.
Images References :
Sb 202474, Which Has No Ability To Inhibit P38 Mapk Activity And Is Widely Used As A Negative Control Compound In P38 Mapk Studies, Also Suppressed Melanin Synthesis Induction [1].
This product has been discontinued.
This Page Contains Chemical Information About Sb 202474.
Therefore, the inactive drug analog will not be used in the array experiments.
Sb 202190 And Sb 203580 Are Potent And Selective Inhibitors Of The Map Kinases P38Α And P38Β [1] [2] [3].